These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14988996)

  • 41. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
    Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
    Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microscopic esophageal mucosal injury in nonerosive reflux disease.
    Dent J
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):4-16. PubMed ID: 17157563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differencial diagnosis of gastroesophageal reflux disease -- eosinophilic esophagitis: case report].
    Franzius M; Stolte M; Porschen R
    Z Gastroenterol; 2005 Apr; 43(4):385-9. PubMed ID: 15830305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
    Xue Y; Zhou LY; Lin SR
    Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrastructural characteristics of the oesophageal mucosa in man.
    Dilly PN; Mallinson CN
    Gut; 1975 Oct; 16(10):841-2. PubMed ID: 1205327
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
    Waśko-Czopnik D; Błoński W; Paradowski L
    Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A clinical study of non-erosive reflux disease].
    Liu Y; Gong J; Dong L; Wang XQ; Zhu YL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):552-4. PubMed ID: 16078586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The clinical, pathological features and expression of Ki-67 and COX-2 in severe reflux esophagitis and Barrett's esophagus].
    Chen X; Ouyang Q; Zhang WY; Li XS; Liang HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):207-9. PubMed ID: 15807268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [GLOSSALGIA SYNDROME AS SUPRAESOPHAGEAL MANIFESTATION OF GASTROESOPHAGEAL REFLUX DISEASE].
    Ostrovskaya LY; Bulkina NV; Osipova UL
    Eksp Klin Gastroenterol; 2015; (6):95-8. PubMed ID: 26817112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastroesophageal Reflux Induces Protein Adducts in the Esophagus.
    Caspa Gokulan R; Adcock JM; Zagol-Ikapitte I; Mernaugh R; Williams P; Washington KM; Boutaud O; Oates JA; Dikalov SI; Zaika AI
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):480-482.e7. PubMed ID: 30827415
    [No Abstract]   [Full Text] [Related]  

  • 53. Feline esophagus.
    Furth EE; Rubesin SE; Rose D
    AJR Am J Roentgenol; 1995 Apr; 164(4):900. PubMed ID: 7726044
    [No Abstract]   [Full Text] [Related]  

  • 54. The human aerodigestive tract and gastroesophageal reflux: an evolutionary perspective.
    Laitman JT; Reidenberg JS
    Am J Med; 1997 Nov; 103(5A):2S-8S. PubMed ID: 9422615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The microbiocenosis of upper parts of digestive tract of children with gastroesophageal reflux disease and chronic gastroduodenitis].
    Apenchenko IuS; Chervinets VM; Ivanova II; Basalaeva NV; Beliaeva EV
    Klin Lab Diagn; 2013 Apr; (4):40-3. PubMed ID: 23984555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinico-immunologic monitoring of patients with gastroesophageal reflux during recuperative treatment].
    Efendieva MT; Razumov AN; Kurbanov FS; Derevnina NA; Gontar' EV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (3):18-20. PubMed ID: 12221838
    [No Abstract]   [Full Text] [Related]  

  • 57. Gastroesophageal reflux disease and atrial fibrillation.
    Letsas KP; Efremidis M; Sideris A
    Int J Cardiol; 2015 Nov; 198():31. PubMed ID: 26149335
    [No Abstract]   [Full Text] [Related]  

  • 58. [The esophagus in relation to gastric pathology].
    PALLESTRINI E
    Minerva Med; 1953 Apr; 44(32):1023-5. PubMed ID: 13071980
    [No Abstract]   [Full Text] [Related]  

  • 59. Exfoliative cytologic study of gastric and esophageal lesions; advantages to the surgeon of the chymotrypsin method.
    MAYO HW; BRUNS HJ; ROTHE IA; PRIOR JT
    Ann Surg; 1958 May; 147(5):733-7. PubMed ID: 13521692
    [No Abstract]   [Full Text] [Related]  

  • 60. [Histologic problems of extensive epithelial heterotopia of the lower esophagus].
    Savary M; Fasel J; Monti M
    Rev Med Suisse Romande; 1970 Jan; 90(1):37-44. PubMed ID: 5417987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.